2 completed, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Aggressive Lymphoma: new trials by email Literature Review of Aggressive Lymphoma trials Research Report on Aggressive Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Of The Selective PKC-β Inhibitor MS- 553 MS-553, acalabrutinib, venetoclax - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 / Phase 2 | Terminated | MingSight Pharmaceuticals, Inc | 60 | 2018-05-25 | 2025-04-10 |
| Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma Bendamustine and subcutaneous rituximab - Aggressive Lymphoma | Phase 2 | Completed | University of Göttingen | 68 | 2012-07-04 | 2018-12-31 |
| Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL Rituximab, Gemcitabine, Oxaliplatin, Dexametasone - Aggressive Lymphoma, Diffuse Large B-cell Lymphoma | Phase 2 | Completed | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 82 | 2011-04-01 | 2017-10-30 |
Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Leukemia (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Lymphoma (1) · Lymphoma, B-Cell (1)
Rituximab (2) · Bendamustine Hydrochloride (1) · Gemcitabine (1) · Oxaliplatin (1) · acalabrutinib (1) · obinutuzumab (1) · venetoclax (1)
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (1) · MingSight Pharmaceuticals, Inc (1) · University of Göttingen (1)
Germany (1) · Spain (1) · United States (1)
Carlos Grande, MD (1) · Carlos Panizo Santos, MD (1) · Isidro Jarque, MD (1) · Javier Briones Meijide, MD (1) · Joan Bargay Leonart, MD (1) · Jorge Gayoso Cruz, MD (1)